vehicle solution (Industrial Farmacéutica Cantabria)

The vehicle solution is an inactive topical placebo formulation developed by Industrial Farmacéutica Cantabria, S.A. (Cantabria Labs). It is specifically utilized in Phase III clinical trials for the treatment of female androgenetic alopecia to maintain the double-blind study design. The solution is formulated to be physically indistinguishable from active topical treatments, such as 2% minoxidil solution, but lacks any active pharmacological ingredients. In the trial setting, it is used in conjunction with oral treatments to ensure that all study arms follow the same topical application regimen, thereby controlling for the placebo effect and ensuring the integrity of the comparative data between oral and topical minoxidil formulations.

Other names

topical vehicle solution